Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.37 |
| ▸ | FABP4 | P15090 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | MITF | O75030 | 1/20 | 0.32 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26634655 | 1.00 | FABP3 (0.37) | FABP3FABP4GAAL3MBTL1ALDH1A1 | |
| SCHEMBL21383848 | 1.00 | FABP3 (0.37) | FABP3FABP4GAAL3MBTL1ALDH1A1 | |
| SCHEMBL26746697 | 0.88 | KMT2A (0.32) | L3MBTL1ALDH1A1KMT2AFOLH1 | |
| SCHEMBL26746691 | 0.88 | KMT2A (0.32) | L3MBTL1ALDH1A1KMT2AFOLH1 | |
| SCHEMBL24795884 | 0.86 | USP2 (0.37) | FABP3FABP4GAAL3MBTL1ALDH1A1 | |
| SCHEMBL21389230 | 0.86 | USP2 (0.37) | FABP3FABP4GAAL3MBTL1ALDH1A1 | |
| SCHEMBL24796027 | 0.84 | CYP1A2 (0.36) | L3MBTL1ALDH1A1KMT2AMITFLMNA | |
| SCHEMBL24796675 | 0.84 | HPGD (0.43) | GAAL3MBTL1ALDH1A1KMT2AMITF | |
| SCHEMBL24796626 | 0.84 | L3MBTL1 (0.38) | FABP3FABP4GAAL3MBTL1ALDH1A1 | |
| SCHEMBL21389372 | 0.84 | L3MBTL1 (0.38) | FABP3FABP4GAAL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. | 2023-11-09 | — | — | US | disclosed |
| CN-112236161-A | Modulators of G protein-coupled receptors | 卡莫特治疗学股份有限公司 | 2021-01-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | GIPR, GLP1R, GCGR | FABP3 666/4885FABP4 1047/4885GAA 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.